Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens
The Company has also started the registration process for Mosept-Oral for the UK with the submission of the documentation for the formulation.
- The Company has also started the registration process for Mosept-Oral for the UK with the submission of the documentation for the formulation.
- Initial target countries are the United Kingdom, Germany, the Netherlands, France, Italy, Spain, Cyprus, Canada and the Middle East.
- The mouth spray was formulated, designed and developed entirely by the Cosmos Holdings research and development team.
- Chlorhexidine is a bisbiguanide antiseptic and disinfectant which is bactericidal or bacteriostatic against a wide range of Gram-positive and Gram-negative bacteria and inhibits the proliferation of certain viruses and fungi.